NCT06314022Recruiting
A Mobile Application to Improve the Quality of Colonoscopy in Colorectal Cancer Screening Program (PrepColon APP)
Design of a Mobile Application to Improve the Quality of Colonoscopy and Its Implementation in Colorectal Cancer Screening Program: a Randomized Multicenter Study (PrepColon APP Study)
Source: ClinicalTrials.gov · Last updated 4 Jun 2026
Brief summary (registry, in English)
Colonoscopy is the gold standard for the diagnosis and resection of preneoplastic lesions, allowing the prevention of colon cancer. A colonoscopy is more efficient with proper preparation of the colon, as it allows for a higher rate of adenoma detection and cecal intubation. In routine practice, up to 30% of colonoscopies are poorly prepared and 11% of patients do not show up for their appointment. Adenomas not visualized in the initial colonoscopy due to poor preparation reached 68% and the rate of undetected cancers was 66.7%. A proper colon cleanse is conditioned by different factors; among them, failure to comply with the diet and take laxatives poses 5 times the risk of having a deficient colon preparation. The purpose of our study is the design and implementation of an app that facilitates the preparation of colonoscopy and evaluates its impact on compliance with diet and laxative intake.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 470 (estimated)
- First submitted
- 5 Mar 2024
- Start date
- 2 May 2024
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Hospital del Rio Hortega
- Diseases
- Colorectal cancer
- NCT number
- NCT06314022
What you commit to
- Study type: Interventional
- Planned participants: 470
- From 2 May 2024 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects at elevated risk of CRC due to family history or inherited polyposis diseases or inflammatory bowel disease
Other
- Refusal to give informed consent.
- Those who do not have a smartphone with a minimum version of the operating system (Android 4.4 or iOS 14, which cover more than 99% of the terminals in use)
- Symptomatic patients
Who the study is looking for
- -Subjects between 50-69 years old from the CRC screening program with FIT (\>100ng/ml).
- Informed consent granted in writing
Age in the registry: 50 years to 74 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Rio Hortega Coordinator of this site? Confirm its status | Valladolid | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.